Resumo

CRISTAR, Florencia; LORENZO, Sebastián  e  NORIA, Sofía. The best of the 2018 ACC Congress. Rev.Urug.Cardiol. [online]. 2018, vol.33, n.2, pp.99-120. ISSN 0797-0048.  https://doi.org/10.29277/cardio.33.2.6.

From March 10 to 12 of this year, the 67th annual meeting of the American College of Cardiology (ACC) was held at the Orange County Convention Center in Orlando, Florida. Undoubtedly, one of the most outstanding events of the cardiological agenda, was attended by more than 13.000 professionals, with prominent international guests and multiple scientific activities. One of the most awaited points of the event was the presentation of the clinical trials; among the 2.719 accepted abstracts, there were 20 works selected to be presented in the Late Breaking Clinical Trials sessions and 17 in the Clinical Research sessions1,2,3 We will make a brief summary of some of the main scientific trials presented: ( The ODYSSEY Outcomes Trial. Alirocumab in Patients After Acute Coronary Syndrome. ( Vest Prevention of Early Sudden Death Trial (VEST). ( TREAT Trial. Ticagrelor vs. Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction. ( NOTION: Five-Year Outcomes From the All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial in Patients with Severe Aortic Valve Stenosis. ( Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing.

Palavras-chave : Acute coronary syndrome; Early prevention of sudden death; Severe aortic valve stenosis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )